Publications by authors named "Maruthsakhi Molugu"
Article Synopsis
- Prospective studies indicate that direct anticoagulants, rivaroxaban and apixaban, are safe and effective when used during radiofrequency ablation (RFA) for atrial fibrillation (AF), though no comparative studies exist.
- A study of 358 patients revealed no significant differences in outcomes or complications between those taking apixaban and those on rivaroxaban during the procedure.
- Results show low rates of thromboembolic events and pericardial effusions for both medications, affirming that their uninterrupted use during AF RFA is safe and comparable.